Royal Bank of Canada
VRTX icon

Royal Bank of Canada’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$616M Buy
1,384,368
+175,700
+15% +$78.2M 0.11% 160
2025
Q1
$586M Sell
1,208,668
-242,291
-17% -$117M 0.12% 149
2024
Q4
$584M Sell
1,450,959
-116,677
-7% -$47M 0.12% 147
2024
Q3
$729M Sell
1,567,636
-113,964
-7% -$53M 0.15% 120
2024
Q2
$788M Buy
1,681,600
+170,396
+11% +$79.9M 0.18% 98
2024
Q1
$632M Buy
1,511,204
+56,732
+4% +$23.7M 0.14% 123
2023
Q4
$592M Buy
1,454,472
+224,276
+18% +$91.3M 0.14% 136
2023
Q3
$428M Buy
1,230,196
+12,630
+1% +$4.39M 0.12% 156
2023
Q2
$428M Buy
1,217,566
+91,890
+8% +$32.3M 0.11% 158
2023
Q1
$355M Buy
1,125,676
+165,244
+17% +$52.1M 0.1% 169
2022
Q4
$277M Buy
960,432
+37,192
+4% +$10.7M 0.08% 200
2022
Q3
$267M Buy
923,240
+38,005
+4% +$11M 0.08% 189
2022
Q2
$249M Buy
885,235
+45,140
+5% +$12.7M 0.07% 213
2022
Q1
$219M Buy
840,095
+136,396
+19% +$35.6M 0.05% 270
2021
Q4
$155M Sell
703,699
-76,891
-10% -$16.9M 0.04% 354
2021
Q3
$142M Sell
780,590
-291,551
-27% -$52.9M 0.04% 352
2021
Q2
$216M Buy
1,072,141
+230,563
+27% +$46.5M 0.06% 266
2021
Q1
$181M Sell
841,578
-35,371
-4% -$7.6M 0.05% 284
2020
Q4
$207M Buy
876,949
+147,020
+20% +$34.7M 0.06% 239
2020
Q3
$199M Buy
729,929
+146,551
+25% +$39.9M 0.07% 210
2020
Q2
$169M Buy
583,378
+50,299
+9% +$14.6M 0.07% 212
2020
Q1
$127M Sell
533,079
-113,549
-18% -$27M 0.06% 224
2019
Q4
$142M Buy
646,628
+36,459
+6% +$7.98M 0.05% 261
2019
Q3
$103M Buy
610,169
+93,736
+18% +$15.9M 0.04% 311
2019
Q2
$94.7M Buy
516,433
+4,635
+0.9% +$850K 0.04% 322
2019
Q1
$94.1M Sell
511,798
-121,747
-19% -$22.4M 0.04% 302
2018
Q4
$105M Buy
633,545
+65,058
+11% +$10.8M 0.05% 275
2018
Q3
$109M Buy
568,487
+71,705
+14% +$13.8M 0.05% 288
2018
Q2
$84.4M Sell
496,782
-70,569
-12% -$12M 0.04% 329
2018
Q1
$92.5M Buy
567,351
+232,183
+69% +$37.8M 0.04% 313
2017
Q4
$50.2M Buy
335,168
+171,670
+105% +$25.7M 0.02% 503
2017
Q3
$24.9M Buy
163,498
+21,527
+15% +$3.27M 0.01% 805
2017
Q2
$18.3M Buy
141,971
+57,178
+67% +$7.37M 0.01% 923
2017
Q1
$9.27M Sell
84,793
-30,920
-27% -$3.38M 0.01% 1276
2016
Q4
$8.53M Sell
115,713
-44,510
-28% -$3.28M ﹤0.01% 1317
2016
Q3
$14M Buy
160,223
+28,630
+22% +$2.5M 0.01% 1027
2016
Q2
$11.3M Buy
131,593
+7,116
+6% +$612K 0.01% 1143
2016
Q1
$9.89M Buy
124,477
+1,218
+1% +$96.8K 0.01% 1181
2015
Q4
$15.5M Buy
123,259
+27,185
+28% +$3.42M 0.01% 973
2015
Q3
$10M Sell
96,074
-37,038
-28% -$3.86M 0.01% 962
2015
Q2
$16.4M Buy
133,112
+28,426
+27% +$3.51M 0.01% 839
2015
Q1
$12.3M Sell
104,686
-71,574
-41% -$8.44M 0.01% 953
2014
Q4
$20.9M Sell
176,260
-215,310
-55% -$25.6M 0.01% 705
2014
Q3
$44M Buy
391,570
+258,763
+195% +$29.1M 0.03% 358
2014
Q2
$12.6M Sell
132,807
-48,381
-27% -$4.58M 0.01% 921
2014
Q1
$12.8M Sell
181,188
-73,583
-29% -$5.2M 0.01% 877
2013
Q4
$18.9M Buy
254,771
+48,655
+24% +$3.62M 0.01% 679
2013
Q3
$15.6M Buy
206,116
+66,316
+47% +$5.03M 0.01% 712
2013
Q2
$11.2M Buy
+139,800
New +$11.2M 0.01% 801